213 related articles for article (PubMed ID: 29596541)
21. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
22. Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
Fellah S; Cheung YT; Scoggins MA; Zou P; Sabin ND; Pui CH; Robison LL; Hudson MM; Ogg RJ; Krull KR
J Natl Cancer Inst; 2019 Feb; 111(2):201-209. PubMed ID: 29790971
[TBL] [Abstract][Full Text] [Related]
23. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate.
Asato R; Akiyama Y; Ito M; Kubota M; Okumura R; Miki Y; Konishi J; Mikawa H
Cancer; 1992 Oct; 70(7):1997-2004. PubMed ID: 1525778
[TBL] [Abstract][Full Text] [Related]
24. Impaired brain metabolism and neurocognitive function in childhood leukemia survivors despite complete hormone supplementation in adulthood.
Follin C; Erfurth EM; Johansson A; Lätt J; Sundgren PC; Österberg K; Spulber G; Mannfolk P; Björkman-Burtscher IM
Psychoneuroendocrinology; 2016 Nov; 73():157-165. PubMed ID: 27498291
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Leukoencephalopathy and Association With Later Neurocognitive Performance in Pediatric Acute Lymphoblastic Leukemia.
Pryweller JR; Glass JO; Sabin ND; Laningham FH; Li Y; Jacola LM; Conklin HM; Reddick WE
Invest Radiol; 2021 Feb; 56(2):117-126. PubMed ID: 32769417
[TBL] [Abstract][Full Text] [Related]
26. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.
Mahmoud HH; Rivera GK; Hancock ML; Krance RA; Kun LE; Behm FG; Ribeiro RC; Sandlund JT; Crist WM; Pui CH
N Engl J Med; 1993 Jul; 329(5):314-9. PubMed ID: 8321259
[TBL] [Abstract][Full Text] [Related]
27. Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination.
Olczak M; Kwiatkowska M; Niderla-Bielińska J; Chutorański D; Tarka S; Wierzba-Bobrowicz T
Folia Neuropathol; 2018; 56(2):97-103. PubMed ID: 30509029
[TBL] [Abstract][Full Text] [Related]
28. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy.
Chu WC; Chik KW; Chan YL; Yeung DK; Roebuck DJ; Howard RG; Li CK; Metreweli C
Radiology; 2003 Dec; 229(3):659-69. PubMed ID: 14576448
[TBL] [Abstract][Full Text] [Related]
29. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
[TBL] [Abstract][Full Text] [Related]
30. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
[TBL] [Abstract][Full Text] [Related]
31. Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.
Cross AH; Gelfand JM; Thebault S; Bennett JL; von Büdingen HC; Cameron B; Carruthers R; Edwards K; Fallis R; Gerstein R; Giacomini PS; Greenberg B; Hafler DA; Ionete C; Kaunzner UW; Kodama L; Lock C; Longbrake EE; Musch B; Pardo G; Piehl F; Weber MS; Yuen S; Ziemssen T; Bose G; Freedman MS; Anania VG; Ramesh A; Winger RC; Jia X; Herman A; Harp C; Bar-Or A
JAMA Neurol; 2024 Mar; 81(4):373-83. PubMed ID: 38466277
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.
Krull KR; Hockenberry MJ; Miketova P; Carey M; Moore IM
Leuk Lymphoma; 2013 Mar; 54(3):535-40. PubMed ID: 22856670
[TBL] [Abstract][Full Text] [Related]
33. F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.
Hockenberry MJ; Taylor OA; Gundy PM; Ross AK; Pasvogel A; Montgomery D; Ribbeck P; McCarthy K; Moore I
Biol Res Nurs; 2014 Jul; 16(3):303-9. PubMed ID: 23956352
[TBL] [Abstract][Full Text] [Related]
34. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
Brouns R; De Vil B; Cras P; De Surgeloose D; Mariën P; De Deyn PP
Clin Chem; 2010 Mar; 56(3):451-8. PubMed ID: 19959621
[TBL] [Abstract][Full Text] [Related]
35. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
[TBL] [Abstract][Full Text] [Related]
36. Association of Plasma Tau With Mortality and Long-term Neurocognitive Impairment in Survivors of Pediatric Cerebral Malaria and Severe Malarial Anemia.
Datta D; Bangirana P; Opoka RO; Conroy AL; Co K; Bond C; Zhao Y; Kawata K; Saykin AJ; John CC
JAMA Netw Open; 2021 Dec; 4(12):e2138515. PubMed ID: 34889945
[TBL] [Abstract][Full Text] [Related]
37. Impact of chemotherapy for childhood leukemia on brain morphology and function.
Genschaft M; Huebner T; Plessow F; Ikonomidou VN; Abolmaali N; Krone F; Hoffmann A; Holfeld E; Vorwerk P; Kramm C; Gruhn B; Koustenis E; Hernaiz-Driever P; Mandal R; Suttorp M; Hummel T; Ikonomidou C; Kirschbaum C; Smolka MN
PLoS One; 2013; 8(11):e78599. PubMed ID: 24265700
[TBL] [Abstract][Full Text] [Related]
38. White matter changes in children treated for acute lymphoblastic leukemia.
Pääkkö E; Vainionpää L; Lanning M; Laitinen J; Pyhtinen J
Cancer; 1992 Dec; 70(11):2728-33. PubMed ID: 1423204
[TBL] [Abstract][Full Text] [Related]
39. Structural and Functional Brain Imaging in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia Treated With Chemotherapy: A Systematic Review.
Gandy K; Scoggins MA; Jacola LM; Litten M; Reddick WE; Krull KR
JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34514328
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
